Vanguard Health Care ETF

VHT

Market cap $16.6B

LLY's $4B vaccine push is boosting interest in healthcare ETFs like IHE with heavy exposure to the drugmaker.

U.S.-Iran tensions rise as Hormuz risks grow. Markets turn volatile -- dividend, low-beta, and defensive ETFs may help cushion portfolios.

Investors are questioning the staying power of medical technology (medtech) stocks, which have fallen from grace since the COVID-19 pandemic. The starting point is to distinguish between medtech and other healthcare industries.

Goldman lifts UnitedHealth's target price, spotlighting ETFs like IHF as diversified ways to tap its growth while cushioning Medicaid-driven risks.

Recent White House and FDA actions fast-track psychedelic depression drug approvals, granting priority review vouchers and accelerating rescheduling for eligible therapies. Compass Pathways leads with a CNPV for COMP360 in treatment-resistant depression, positive Phase 3 data, and a sub-$1bn market cap suggesting potential upside.

If you're interested in broad exposure to the Healthcare - Broad segment of the equity market, look no further than the Vanguard Health Care Index Fund ETF Shares (VHT), a passively managed exchange traded fund launched on January 26, 2004.

Expected increased capital spending and the implementation of artificial intelligence (AI) are structural tailwinds for healthcare stocks today. Spending is expected to be 20% of GDP by 2032.

After a 50%+ run from lows last April through highs in mid-January, the Biotech group has been trending sideways over the last few months. Biotech hasn't garnered much attention lately, with all the coverage of the Iran War and the AI Doom trade that's been taking down software stocks even as AI infrastructure stocks continue to surge.

Many portfolios are still very heavy in tech and growth stocks. It's time to revisit asset allocations.

Healthcare spending doesn't stop during recessions. That structural reality is the core argument for owning Vanguard Health Care ETF (NYSEARCA:VHT), a pure-play sector fund that has quietly compounded wealth for long-term investors while offering insulation from economic cycles that most equity sectors can't match.